Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Malignant Skin Neoplasm”

241 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 241 results

Testing effectiveness (Phase 2)Study completedNCT00002475
What this trial is testing

Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer

Who this might be right for
Breast CancerColorectal CancerKidney Cancer+3 more
St. Vincent Medical Center - Los Angeles 40
Testing effectiveness (Phase 2)Study completedNCT00281957
What this trial is testing

Sorafenib With Either Temsirolimus or Tipifarnib in Treating Patients With Stage IV Malignant Melanoma That Cannot Be Removed By Surgery

Who this might be right for
Recurrent MelanomaStage IV Melanoma
National Cancer Institute (NCI) 109
Testing effectiveness (Phase 2)Ended earlyNCT01120275
What this trial is testing

Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Stage IV Melanoma

Who this might be right for
Acral Lentiginous Malignant MelanomaLentigo Maligna Malignant MelanomaNodular Malignant Melanoma+4 more
National Cancer Institute (NCI) 36
Early research (Phase 1)Study completedNCT00161187
What this trial is testing

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

Who this might be right for
Cancer
University of Medicine and Dentistry of New Jersey 37
Early research (Phase 1)Study completedNCT00060372
What this trial is testing

Ipilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive Cancer

Who this might be right for
Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Inv(16)(p13;q22)Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)+59 more
National Cancer Institute (NCI) 21
Early research (Phase 1)Study completedNCT01005472
What this trial is testing

Temozolomide and Sunitinib Malate in Treating Patients With Stage III or Stage IV Malignant Melanoma

Who this might be right for
Metastatic Melanoma
Jonsson Comprehensive Cancer Center 16
Not applicableWithdrawnNCT01558778
What this trial is testing

Mechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell Transplant

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+100 more
Roswell Park Cancer Institute
Testing effectiveness (Phase 2)WithdrawnNCT03739606
What this trial is testing

Flotetuzumab in Treating Patients With Recurrent or Refractory CD123 Positive Blood Cancer

Who this might be right for
Acute Biphenotypic LeukemiaAcute LeukemiaChronic Myelogenous Leukemia, BCR-ABL1 Positive+12 more
City of Hope Medical Center
Testing effectiveness (Phase 2)Ended earlyNCT03404193
What this trial is testing

Venetoclax and Decitabine in Treating Participants With Relapsed/Refractory Acute Myeloid Leukemia or Relapsed High-Risk Myelodysplastic Syndrome

Who this might be right for
Acute Myeloid LeukemiaAcute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeBlastic Plasmacytoid Dendritic Cell Neoplasm+12 more
M.D. Anderson Cancer Center 235
Testing effectiveness (Phase 2)Ended earlyNCT03246906
What this trial is testing

Comparison of Triple GVHD Prophylaxis Regimens for Nonmyeloablative or Reduced Intensity Conditioning Unrelated Mobilized Blood Cell Transplantation

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAggressive Non-Hodgkin Lymphoma+14 more
Fred Hutchinson Cancer Center 150
Testing effectiveness (Phase 2)Study completedNCT00004022
What this trial is testing

Biological Therapy Following Surgery in Treating Patients With Stage III or Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
Barbara Ann Karmanos Cancer Institute
Not applicableWithdrawnNCT00898612
What this trial is testing

Early Detection of Graft-Versus-Host Disease in Patients Undergoing a Donor Bone Marrow Transplant

Who this might be right for
Lymphoma
Mayo Clinic
Early research (Phase 1)Active Not RecruitingNCT03696030
What this trial is testing

HER2-CAR T Cells in Treating Patients With Recurrent Brain or Leptomeningeal Metastases

Who this might be right for
Malignant NeoplasmMetastatic Malignant Neoplasm in the BrainMetastatic Malignant Neoplasm in the Leptomeninges+2 more
City of Hope Medical Center 24
Testing effectiveness (Phase 2)Looking for participantsNCT04550494
What this trial is testing

Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations

Who this might be right for
Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8Castration-Resistant Prostate Carcinoma+28 more
National Cancer Institute (NCI) 36
Testing effectiveness (Phase 2)Study completedNCT03153085
What this trial is testing

Combination with TBI-1401(HF10) and Ipilimumab in Japanese Patients with Unresectable or Metastatic Melanoma

Who this might be right for
Melanoma Stage IIIMelanoma Stage IV
Takara Bio Inc. 28
Large-scale testing (Phase 3)Ended earlyNCT00324324
What this trial is testing

Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
OHSU Knight Cancer Institute 240
Testing effectiveness (Phase 2)Study completedNCT00026143
What this trial is testing

Interleukin-12 and Interferon Alfa in Treating Patients With Metastatic Malignant Melanoma

Who this might be right for
Recurrent MelanomaStage IV Melanoma
National Cancer Institute (NCI) 60
Early research (Phase 1)Study completedNCT01231919
What this trial is testing

MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Leukemias of Ambiguous LineageAcute Myeloid Leukemia/Transient Myeloproliferative Disorder+48 more
National Cancer Institute (NCI) 45
Not applicableStudy completedNCT00477919
What this trial is testing

E-MOSAIC Electronic Tool to Monitor Symptoms

Who this might be right for
Cancer
Swiss Cancer Institute 264
Early research (Phase 1)Study completedNCT00027534
What this trial is testing

Vaccine Therapy in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Breast CancerColorectal CancerGallbladder Cancer+6 more
Michael Morse, MD 14
Load More Results